Fintel reports that on January 10, 2025, Morgan Stanley upgraded their outlook for Gilead Sciences (NasdaqGS:GILD) from Equal ...

The stock's rise snapped a five-day losing streak.

In this guest commentary, Caleb Appleton, a principal at Bison Ventures, offers up a framework biotech founders can use to ...